110351-91-2
110351-91-2
Chemical Structure
(R)-Exatecan Intermediate 1
- CAS No.: 110351-91-2
- Formula:C13H13NO5
- Molecular Weight:263.25
IUPAC Name: (R)-4-ethyl-4-hydroxy-7,8-dihydro-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione
InChIKey: IGKWOGMVAOYVSJ-CYBMUJFWSA-N
SMILES: O=C1[C@@](O)(CC)C(C=C23)=C(CO1)C(N3CCC2=O)=O
Biological Activity: (R)-Exatecan Intermediate 1 is a key intermediate in the synthesis of Camptothecin (HY-16560) derivatives, and can be used to prepare Exatecan mesylate (DX8951f) (HY-13631A). (R)-Exatecan Intermediate 1 enables the synthesis of Exatecan, which exhibits low sensitivity to multidrug resistance and has great value in anti-tumor research[1][2][3].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
(R)-Exatecan Intermediate 1 | (R)-Exatecan Intermediate 1 is a key intermediate in the synthesis of Camptothecin (HY-16560) derivatives, and can be used to prepare Exatecan mesylate (DX8951f) (HY-13631A). (R)-Exatecan Intermediate 1 enables the synthesis of Exatecan, which exhibits low sensitivity to multidrug resistance and has great value in anti-tumor research. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Zhong MinLin, et al. Self-driven water collecting surface with superhydrophobic-superhydrophilic structure and preparation method therefor. WO2020000868A1.
- [2]. Weng W, et al. Antibody-Exatecan Conjugates with a Novel Self-immolative Moiety Overcome Resistance in Colon and Lung Cancer. Cancer Discov. 2023;13(4):950-973. [Content Brief]
- [3]. Conilh L, et al. Exatecan Antibody Drug Conjugates Based on a Hydrophilic Polysarcosine Drug-Linker Platform. Pharmaceuticals (Basel). 2021;14(3):247. Published 2021 Mar 9. [Content Brief]
